Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data

J Am Acad Dermatol. 2010 Jun;62(6):1067-9. doi: 10.1016/j.jaad.2009.07.010.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Arthritis, Psoriatic / complications
  • Arthritis, Psoriatic / drug therapy*
  • Etanercept
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / pathology
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / therapeutic use*
  • Liver / drug effects*
  • Liver / pathology
  • Male
  • Middle Aged
  • Psoriasis / complications
  • Psoriasis / drug therapy*
  • Receptors, Tumor Necrosis Factor / therapeutic use*

Substances

  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Etanercept